Key facts
- It has raised $11.0M; the latest was Later Stage VC ($7.0M) in Aug 2024.
- Notable investors include David Scott, Greg Hoffman, Kenston Capital Partners, Xator.
- NanoHive Medical has filed 2 Form Ds with the SEC, most recently Nov 2022 ( sold).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for NanoHive Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for NanoHive Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NanoHive Medical
Developer of three-dimensional-printed spinal interbody implants and instruments designed to address spinal fusion challenges with bioactive titanium devices. The company's product offers biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction, and integration, enabling surgeons and their patients with instruments that lead to consistently robust fusion constructs and efficacious clinical experiences.
- Sector
- Healthcare
- HQ
- Woburn, MA, United States
- Founded
- 2014
- Employees
- 19
- Website
- nanohive.com/
- Ownership
- Privately Held (backing)
NanoHive Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NanoHive Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NanoHive Medical in its N-PORT filings yet. We sweep new filings monthly.